(1) Includes $2,553, $2,486, and $2,853 related to stock-based compensation in 1Q17, 4Q16, and 1Q16, respectively.

Analog Devices, First Quarter, Fiscal 2017
Schedule C
Cash Flow Statement (Unaudited)
(In thousands)
				Three Months Ended
				1Q 17						4Q 16						1Q 16
				Jan. 28, 2017						Oct. 29, 2016						Jan. 30, 2016
Cash flows from operating activities:
Net Income				$	217,129					$	296,157					$	164,504
Adjustments to reconcile net income
to net cash provided by operations:
Depreciation				34,379						34,116						33,209
Amortization of intangibles				19,947						19,547						18,347
Stock-based compensation expense				16,529						15,234						15,609
Loss on extinguishment of debt				—						—						3,290
Other non-cash activity				13,071						22,199						744
Excess tax benefit - stock options				(8,102		)				(3,273		)				(986		)
Deferred income taxes				(7,055		)				(12,941		)				(7,717		)
Changes in operating assets and liabilities				28,594						115,945						(7,295		)
Total adjustments				97,363						190,827						55,201
Net cash provided by operating activities				314,492						486,984						219,705
Percent of revenue				31.9		%				48.5		%				28.6		%
Cash flows from investing activities:
Purchases of short-term available-for-sale investments				(326,908		)				(1,841,330		)				(1,632,014		)
Maturities of short-term available-for-sale investments				1,844,380						1,364,419						1,409,538
Sales of short-term available-for-sale investments				287,601						42,645						47,950
Additions to property, plant and equipment				(28,337		)				(41,224		)				(23,128		)
Payments for acquisitions, net of cash acquired				(1,036		)				(80,967		)				—
Change in other assets				(5,946		)				(472		)				(6,711		)
Net cash used for investing activities				1,769,754						(556,929		)				(204,365		)
Cash flows from financing activities:
Payments of senior unsecured notes				—						—						(378,156		)
Proceeds from (payments of) derivative instruments				3,904						—						(33,430		)
Proceeds from debt				2,072,306						—						1,235,331
Payments for deferred financing fees				(5,625		)				(4,375		)				—
Dividend payments to shareholders				(129,683		)				(129,643		)				(124,658		)
Repurchase of common stock				(3,106		)				(1,412		)				(131,977		)
Proceeds from employee stock plans				34,432						22,154						6,229
Excess tax benefit - stock options				8,102						3,273						986
Contingent consideration payment				—						(1,409		)				—
Change in other financing activities				2,221						45						(2,544		)
Net cash provided by (used for) financing activities				1,982,551						(111,367		)				571,781
Effect of exchange rate changes on cash				(666		)				(1,226		)				(1,032		)
Net increase (decrease) in cash and cash equivalents				4,066,131						(182,538		)				586,089
Cash and cash equivalents at beginning of period				921,132						1,103,670						884,353
Cash and cash equivalents at end of period				$	4,987,263					$	921,132					$	1,470,442